SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,484 | -50.3% | 49,363 | 0.0% | 0.04% | -40.3% |
| Q2 2023 | $236,449 | -15.5% | 49,363 | 0.0% | 0.07% | -28.7% |
| Q1 2023 | $279,888 | +1.2% | 49,363 | 0.0% | 0.09% | +1.1% |
| Q4 2022 | $276,433 | -12.8% | 49,363 | 0.0% | 0.09% | -10.6% |
| Q3 2022 | $317,000 | +87.6% | 49,363 | 0.0% | 0.10% | +89.1% |
| Q2 2022 | $169,000 | -51.9% | 49,363 | 0.0% | 0.06% | -23.6% |
| Q1 2022 | $351,000 | -14.6% | 49,363 | 0.0% | 0.07% | +35.8% |
| Q4 2021 | $411,000 | +19.5% | 49,363 | 0.0% | 0.05% | +65.6% |
| Q3 2021 | $344,000 | -70.8% | 49,363 | 0.0% | 0.03% | -71.7% |
| Q2 2021 | $1,177,000 | +15.8% | 49,363 | 0.0% | 0.11% | -16.9% |
| Q1 2021 | $1,016,000 | -50.6% | 49,363 | -41.2% | 0.14% | -83.1% |
| Q4 2020 | $2,056,000 | – | 83,903 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |